Breaking News Instant updates and real-time market news.

PACB

Pacific Biosciences

$4.35

0.31 (7.67%)

, HEI

Heico

$77.37

0.41 (0.53%)

10:34
08/09/18
08/09
10:34
08/09/18
10:34

On The Fly: Top analyst initiations

Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Pacific Biosciences (PACB) initiated with an Overweight at Cantor Fitzgerald by analyst Jordan Abrams, who thinks Pacific's long-read next generation sequencing platform is the industry standard for deep genomic analysis in human, plant, and animal genomes, as well as RNA. 2. Heico (HEI) initiated with a Neutral at Baird. 3. Zynga (ZNGA) initiated with an Underweight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

PACB

Pacific Biosciences

$4.35

0.31 (7.67%)

HEI

Heico

$77.37

0.41 (0.53%)

ZNGA

Zynga

$3.87

-0.075 (-1.90%)

  • 09

    Aug

  • 13

    Sep

  • 06

    Nov

PACB Pacific Biosciences
$4.35

0.31 (7.67%)

08/09/18
CANT
08/09/18
INITIATION
Target $5
CANT
Overweight
Cantor starts Pacific Biosciences with Overweight rating, $5 target
Cantor Fitzgerald analyst Jordan Abrams last night initiated coverage of Pacific Biosciences of California with an Overweight rating and $5 price target. The analyst thinks Pacific's long-read next generation sequencing platform is the industry standard for deep genomic analysis in human, plant, and animal genomes, as well as RNA. While the company has seen mixed revenue performance over the past three years, it is "getting close to an inflection point," which the Street is missing, Abrams told investors in a research note. He sees "multiple paths to revenue acceleration."
08/08/18
CANT
08/08/18
INITIATION
Target $5
CANT
Overweight
Pacific Biosciences initiated with an Overweight at Cantor Fitzgerald
Cantor analyst Jordan Abrams initiated Pacific Biosciences with an Overweight and $5 price target.
07/18/18
PIPR
07/18/18
NO CHANGE
Target $3.25
PIPR
Neutral
Pacific Biosciences Q2 shaping up as good quarter, says Piper Jaffray
Piper Jaffray analyst William Quirk says his channel checks found 15 Sequels placed in Q2, suggesting Pacific Biosciences had a sequential increase in placements, consistent with management's comments on the Q1 call and slightly ahead of his expectations. The company's Q2 appears to be shaping up as a good quarter ahead of its 2019 introduction of the 8M feature chip, Quirk tells investors in a research note. The analyst is "encouraged" with Pacific's progress, but keeps a Neutral rating on the shares with a $3.25 price target citing the "complex competitive dynamics."
04/13/18
PIPR
04/13/18
NO CHANGE
Target $3.8
PIPR
Neutral
Pacific Biosciences Sequel installs could be light in Q1, says Piper Jaffray
Following his quarterly channel checks, Piper Jaffray analyst William Quirk lowered his estimated Sequel installs for Pacific Biosciences' Q1 to 26 from 30. The analyst believes there could be some risk to the quarter based on the light amount of suggested installs. Quirk keeps a Neutral rating on Pacific Biosciences with a $3.80 price target.
HEI Heico
$77.37

0.41 (0.53%)

08/08/18
BARD
08/08/18
INITIATION
Target $84
BARD
Neutral
Heico initiated with a Neutral at Baird
Baird analyst Peter Arment initiated Heico with a Neutral and $84 price target.
01/08/18
JEFF
01/08/18
UPGRADE
Target $113
JEFF
Buy
Heico upgraded to Buy from Hold at Jefferies
Jefferies analyst Sheila Kahyaoglu upgraded Heico Corporation to Buy and raised her price target for the shares to $113 from $103. Accelerating organic revenue combined with acquisition contribution are likely to outpace fiscal 2018 guidance, Kahyaoglu tells investors in a research note. The analyst believes strong free cash flow generation and Heico's low leverage could result in additional inorganic earnings accretion.
12/20/17
FBCO
12/20/17
NO CHANGE
Target $109
FBCO
Outperform
Heico price target raised to $109 from $98 at Credit Suisse
Credit Suisse analyst R. Spingarn raised his price target for Heico to $109 from $98 saying he remains constructive on the shares despite the premium valuation and the recent run in the stock. The analyst reiterates an Outperform rating on the shares.
12/20/17
ADAM
12/20/17
NO CHANGE
Target $110
ADAM
Buy
Heico price target raised to $110 from $95 at Canaccord
Canaccord analyst Ken Herbert raised his price target on Heico to $110 from $95 following its better than expected Q4 results. The analyst raised his estimates to reflect a higher contribution from acquisitions than is in the full year guidance and he believes the transition to stronger growth in defense markets will not negatively impact the stocks' valuation. Herbert reiterated his Buy rating on Heico shares.
ZNGA Zynga
$3.87

-0.075 (-1.90%)

08/09/18
LEHM
08/09/18
INITIATION
Target $3.7
LEHM
Underweight
Barclays starts Zynga with Underweight rating, $3.70 price target
Barclays analyst Ryan Gee initiated coverage of Zynga with an Underweight rating and $3.70 price target. At 13 times 2019 EBITDA expectations, the stock already reflects solid future execution, Gee tells investors in a research note. He believes that for Zynga to sustain its "premium" multiple, the company must further close the "wide margin gap" relative to peers by accelerating bookings or greatly rationalizing operating expenditures. Much of the "easy" work to grow margins has already happened, Gee contends. He sees more upside elsewhere in the Internet/Gaming group.
08/01/18
BARD
08/01/18
NO CHANGE
Target $4
BARD
Neutral
Zynga Q2 results roughly in line, says Baird
Baird analyst Colin Sebastian kept his Neutral rating and $4 price target on Zynga after its Q2 results. The analyst notes that the 12% rise in bookings to $233.9M was above consensus of $230.4M thanks to continued growth in Mobile, while adjusted EBITDA of $43.6M was above consensus of about $40M. Sebastian adds that Zynga's "mobile momentum of forever franchises continues to increase, while cost efficiencies drive significant margin improvements" for the company.
05/31/18
PIPR
05/31/18
NO CHANGE
Target $5
PIPR
Overweight
Zynga acquisition adds growing revenue stream, says Piper Jaffray
Piper Jaffray analyst Michael Olson says Zynga's $250M acquisition of Gram Games brings a profitably growing revenue stream. Gram brings a development team that has been responsible for several solid titles, including the company's most successful title, Merge Dragons, Olson tells investors in a research note. He believes Zynga is "building a pipeline of new titles and has several potential growth drivers." The analyst maintains an Overweight rating on the shares with a $5 price target.
05/31/18
BNCH
05/31/18
NO CHANGE
Target $5
BNCH
Buy
Zynga price target raised to $5 after Gram Games deal at Benchmark
Benchmark analyst Mike Hickey raised his price target on Zynga to $5 from $4.36 and reiterated his Buy rating after the company announced the acquisition of mobile game developer Gram Games. He contends the "swimmingly boring" deal should drive considerable EBITDA growth while leveraging Zynga's strength in established genres. Hickey also believes this and other potential M&A along with new game launches should help drive bookings growth and continued EBITDA acceleration.

TODAY'S FREE FLY STORIES

COF

Capital One

$81.53

-0.93 (-1.13%)

, MCO

Moody's

$145.15

-0.75 (-0.51%)

13:55
12/11/18
12/11
13:55
12/11/18
13:55
Conference/Events
House Financial Services Committee to hold a hearing »

The Financial…

COF

Capital One

$81.53

-0.93 (-1.13%)

MCO

Moody's

$145.15

-0.75 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

GE

General Electric

$6.78

-0.145 (-2.10%)

13:50
12/11/18
12/11
13:50
12/11/18
13:50
Options
Put spread in General Electric may adjust downside position »

Put spread in General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KAI

Kadant

$82.62

1.19 (1.46%)

13:47
12/11/18
12/11
13:47
12/11/18
13:47
Upgrade
Kadant rating change  »

Kadant upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 20

    Dec

SHPG

Shire

$169.43

-0.69 (-0.41%)

13:39
12/11/18
12/11
13:39
12/11/18
13:39
Downgrade
Shire rating change  »

Shire downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Dec

PVTL

Pivotal Software

$18.04

0.01 (0.06%)

, AEO

American Eagle

$19.20

-0.32 (-1.64%)

13:35
12/11/18
12/11
13:35
12/11/18
13:35
Earnings
Notable companies reporting after market close »

Notable companies…

PVTL

Pivotal Software

$18.04

0.01 (0.06%)

AEO

American Eagle

$19.20

-0.32 (-1.64%)

PLAY

Dave & Buster's

$51.20

-1.32 (-2.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 14

    Dec

  • 19

    Dec

  • 20

    Dec

NURO

NeuroMetrix

$0.84

0.029 (3.58%)

, GSK

GlaxoSmithKline

$37.39

-0.29 (-0.77%)

13:32
12/11/18
12/11
13:32
12/11/18
13:32
Hot Stocks
NeuroMetrix reports agreement with GSK on 2019 Quell joint development program »

NeuroMetrix (NURO)…

NURO

NeuroMetrix

$0.84

0.029 (3.58%)

GSK

GlaxoSmithKline

$37.39

-0.29 (-0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$48.74

-1.04 (-2.09%)

13:30
12/11/18
12/11
13:30
12/11/18
13:30
Periodicals
CBS meeting adjourns without discussion of Moonves probe, NY Post says »

CBS stakeholders quickly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 19

    Dec

  • 20

    Dec

NBR

Nabors Industries

$2.79

0.03 (1.09%)

13:30
12/11/18
12/11
13:30
12/11/18
13:30
Options
Repeat call buying in Nabors »

Repeat call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

TPR

Tapestry

$35.13

-0.68 (-1.90%)

13:25
12/11/18
12/11
13:25
12/11/18
13:25
Options
Tapestry call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCT

Arcturus Therapeutics

$5.11

(0.00%)

13:25
12/11/18
12/11
13:25
12/11/18
13:25
Conference/Events
Arcturus Therapeutics to hold a conference call »

Key Opinion Leader…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

UBER

Uber

$0.00

(0.00%)

13:22
12/11/18
12/11
13:22
12/11/18
13:22
Periodicals
Uber being sued by defunct ride-hailing 'pioneer' Sidecar, Reuters says »

Sidecar Technologies, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/11/18
12/11
13:17
12/11/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$220.34

3.68 (1.70%)

13:17
12/11/18
12/11
13:17
12/11/18
13:17
Hot Stocks
Align Technology files three additional patent infringement suits against 3Shape »

Align Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/11/18
12/11
13:16
12/11/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
12/11/18
12/11
13:15
12/11/18
13:15
General news
Treasury's $38 B 3-year auction was fairly well received »

Treasury's $38 B…

13:15
12/11/18
12/11
13:15
12/11/18
13:15
General news
Treasury Action: the 3-year yield backed up from lows »

Treasury Action: the…

13:05
12/11/18
12/11
13:05
12/11/18
13:05
General news
3-Yr Note Auction CUSIP Number data reported »

3-Yr Note Auction CUSIP…

13:05
12/11/18
12/11
13:05
12/11/18
13:05
General news
3-Yr Note Auction Total Amount data reported »

3-Yr Note Auction Total…

13:05
12/11/18
12/11
13:05
12/11/18
13:05
General news
FX Action: USD-JPY »

FX Action: USD-JPY topped…

WYNMF

Wynn Macau

$0.00

(0.00%)

12:51
12/11/18
12/11
12:51
12/11/18
12:51
Downgrade
Wynn Macau rating change  »

Wynn Macau downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCHYY

Sands China

$0.00

(0.00%)

12:51
12/11/18
12/11
12:51
12/11/18
12:51
Downgrade
Sands China rating change  »

Sands China downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLCO

Melco Resorts & Entertainment

$17.59

0.58 (3.41%)

12:50
12/11/18
12/11
12:50
12/11/18
12:50
Options
Melco Resorts calls active as shares rally 3.7% »

Melco Resorts calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOD

Vodafone

$20.19

0.055 (0.27%)

, LBTYA

Liberty Global

$22.70

-0.96 (-4.06%)

12:46
12/11/18
12/11
12:46
12/11/18
12:46
Hot Stocks
EU opens in-depth probe into Vodafone's proposed purchase of Liberty assets »

The European Commission…

VOD

Vodafone

$20.19

0.055 (0.27%)

LBTYA

Liberty Global

$22.70

-0.96 (-4.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
12/11/18
12/11
12:45
12/11/18
12:45
General news
Treasury 3-year auction preview: the auction could see headwinds »

Treasury 3-year auction…

GS

Goldman Sachs

$176.97

-1.93 (-1.08%)

, UBER

Uber

$0.00

(0.00%)

12:44
12/11/18
12/11
12:44
12/11/18
12:44
Periodicals
Uber selects Morgan Stanley to lead IPO, Bloomberg reports »

Uber Technologies has…

GS

Goldman Sachs

$176.97

-1.93 (-1.08%)

UBER

Uber

$0.00

(0.00%)

MS

Morgan Stanley

$40.47

-0.22 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.